ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
The COVID-19 pandemic that began in late 2019 continues with new challenges arising due to antigenic drift as well as individuals who cannot or choose not to take the vaccine. There is therefore an urgent need for additional therapies that complement vaccines and approved therapies such as antibodie...
Saved in:
Main Authors: | Lennox Chitsike, John Krstenansky, Penelope J. Duerksen-Hughes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Advances in Pharmacological and Pharmaceutical Sciences |
Online Access: | http://dx.doi.org/10.1155/2021/1828792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interaction mechanism of egg white- derived ACE inhibitory peptide TNGIIR with ACE and its effect on the expression of ACE and AT1 receptor
by: Zhipeng Yu, et al.
Published: (2020-03-01) -
Structural requirements and interaction mechanisms of ACE inhibitory peptides: molecular simulation and thermodynamics studies on LAPYK and its modified peptides
by: Biying Zhang, et al.
Published: (2022-11-01) -
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01) -
Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01) -
Sleep: An unplayed ace in research and treatment of youth with ACEs
by: Sarah L.H. Kamhout, et al.
Published: (2025-04-01)